ALPS Advisors’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166K | Buy |
+46,165
| New | +$166K | ﹤0.01% | 1013 |
|
|
2024
Q4 | – | Sell |
-64,692
| Closed | -$217K | – | 997 |
|
|
2024
Q3 | $217K | Sell |
64,692
-986
| -2% | -$3.3K | ﹤0.01% | 977 |
|
|
2024
Q2 | $217K | Buy |
65,678
+6,311
| +11% | +$20.9K | ﹤0.01% | 947 |
|
|
2024
Q1 | $240K | Buy |
59,367
+931
| +2% | +$3.76K | ﹤0.01% | 955 |
|
|
2023
Q4 | $178K | Sell |
58,436
-3,137
| -5% | -$9.57K | ﹤0.01% | 946 |
|
|
2023
Q3 | $185K | Buy |
61,573
+271
| +0.4% | +$813 | ﹤0.01% | 959 |
|
|
2023
Q2 | $229K | Buy |
61,302
+6,395
| +12% | +$23.9K | ﹤0.01% | 964 |
|
|
2023
Q1 | $184K | Sell |
54,907
-1,705
| -3% | -$5.71K | ﹤0.01% | 987 |
|
|
2022
Q4 | $272K | Buy |
+56,612
| New | +$272K | ﹤0.01% | 934 |
|